Concepedia
Statistics
Publications
28
Citations
1.3K
H-Index
20
Active since
1980
Affiliations
Tennessee Oncology(Current)
Vanderbilt University
Vanderbilt University Medical Center
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Stephen M. Schleicher is an author at Tennessee Oncology specializing in medicine, oncology, and molecular oncology.
Publications per year
1980–2025
Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
Ryan Morrison, Stephen M. Schleicher, Yunguang Sun et al. · Journal of Oncology · 2010 · 245 citations · Full text
Medicine, Cancer Biology, Oncology +17
Dynamics of aquaporin-2 serine-261 phosphorylation in response to short-term vasopressin treatment in collecting duct
Jason D. Hoffert, Jakob Nielsen, Ming‐Jiun Yu et al. · American Journal of Physiology-Renal Physiology · 2006 · 153 citations
Life Sciences, Biochemistry, Physiology +15
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
Howa Yeung, Joy Wan, Abby S. Van Voorhees et al. · Journal of the American Academy of Dermatology · 2012 · 122 citations · Full text
Medicine, Dermatology, Pharmacotherapy +5
Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD
Trairak Pisitkun, Vinitha Jacob, Stephen M. Schleicher et al. · American Journal of Physiology-Renal Physiology · 2008 · 80 citations · Full text
Life Sciences, Cell Biology, Physiology +17
Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells
Yunguang Sun, Siyuan Zheng, Artour Torossian et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 67 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 28